RecruitingPhase 3NCT07654374
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Las Vegas, NV · +73 more sites
Clinical trials in Las Vegas, NV
132 recruiting studies have a site in or near Las Vegas, NV, Nevada.
Top conditions here
- Obesity (16)
- Type 2 Diabetes (14)
- Lung Cancer (11)
- Parkinson's Disease (11)
- Alzheimer's Disease (9)
- Leukemia (8)
- Schizophrenia (8)
- Crohn's Disease (7)
All conditions
- Alzheimer's Disease
- Asthma
- Breast Cancer
- COPD
- Crohn's Disease
- Depression
- Type 1 Diabetes
- Type 2 Diabetes
- Heart Failure
- Hypertension
- Leukemia
- Lung Cancer
- Lupus
- Migraine
- Multiple Sclerosis
- Obesity
- Parkinson's Disease
- Prostate Cancer
- Psoriasis
- Rheumatoid Arthritis
- Schizophrenia
- Sickle Cell Disease
- Ulcerative Colitis
- Colorectal Cancer
Showing 40 of 132 studies
RecruitingPhase 2NCT07752979
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Sponsor: AbbVie
Las Vegas, NV · +58 more sites
RecruitingPhase 3NCT03150693
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Sponsor: Alliance for Clinical Trials in Oncology
Carson City, NV · Henderson, NV · +452 more sites
RecruitingPhase 3NCT04267848
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Sponsor: National Cancer Institute (NCI)
Carson City, NV · Henderson, NV · +1147 more sites
RecruitingPhase 2NCT06317662
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Sponsor: National Cancer Institute (NCI)
Las Vegas, NV · +114 more sites
RecruitingPhase 4NCT07221877
A Study to Evaluate the Effect of KarXT on Urological Safety
Sponsor: Bristol-Myers Squibb
Las Vegas, NV · +15 more sites
RecruitingPhase 2NCT07527650
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
Sponsor: Hanmi Pharmaceutical Company Limited
Las Vegas, NV · +19 more sites
RecruitingPhase 2NCT05554393
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Sponsor: National Cancer Institute (NCI)
Las Vegas, NV · +173 more sites
RecruitingPhase 2NCT07610395
Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD
Sponsor: Altesa Biosciences, Inc.
Las Vegas, NV · +36 more sites
RecruitingPhase 3NCT07674654
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Sponsor: Kallyope Inc.
Las Vegas, NV · +110 more sites
RecruitingNot applicableNCT07005050
Renal Pelvic Denervation Pilot Trial
Sponsor: Verve Medical, Inc
Las Vegas, NV · +8 more sites
RecruitingPhase 3NCT07011732
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Sponsor: Bristol-Myers Squibb
Las Vegas, NV · +40 more sites
RecruitingPhase 3NCT07181109
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Sponsor: Alnylam Pharmaceuticals
Las Vegas, NV · +270 more sites
RecruitingPhase 3NCT07424404
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Las Vegas, NV · +55 more sites
RecruitingPhase 2NCT07459647
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
Sponsor: MapLight Therapeutics
Las Vegas, NV · +44 more sites
RecruitingPhase 2NCT07697456
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Sponsor: AbbVie
Las Vegas, NV · +59 more sites
RecruitingPhase 2NCT06317649
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Sponsor: National Cancer Institute (NCI)
Las Vegas, NV · +223 more sites
RecruitingPhase 3NCT07064473
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Sponsor: Boehringer Ingelheim
Las Vegas, NV · +205 more sites
RecruitingPhase 4NCT07609914
A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine
Sponsor: Pfizer
Las Vegas, NV · +19 more sites
RecruitingPhase 3NCT07816367
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Sponsor: Kallyope Inc.
Las Vegas, NV · +71 more sites
RecruitingPhase 2NCT06656416
ALTO-100 in Bipolar Disorder With Depression (BD-D)
Sponsor: Alto Neuroscience
Las Vegas, NV · +56 more sites
RecruitingPhase 3NCT06841354
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
Sponsor: Merck Sharp & Dohme LLC
Las Vegas, NV · Reno, NV · +37 more sites
RecruitingPhase 3NCT06966700
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Sponsor: Merck Sharp & Dohme LLC
Las Vegas, NV · Reno, NV · +62 more sites
RecruitingPhase 3NCT06989112
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Sponsor: AstraZeneca
Las Vegas, NV · +62 more sites
RecruitingPhase 3NCT07116967
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Sponsor: Bristol-Myers Squibb
Las Vegas, NV · North Las Vegas, NV · +120 more sites
RecruitingPhase 3NCT07216703
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Sponsor: Merck Sharp & Dohme LLC
Las Vegas, NV · +29 more sites
RecruitingPhase 3NCT07484217
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
Sponsor: Axsome Therapeutics, Inc.
Las Vegas, NV · +38 more sites
RecruitingPhase 2NCT06031688
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Sponsor: SWOG Cancer Research Network
Las Vegas, NV · +276 more sites
RecruitingPhase 2NCT07646613
Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
Sponsor: Aspeya, Inc.
Las Vegas, NV · +19 more sites
RecruitingPhase 2NCT06996652
An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)
Sponsor: Yale University
Las Vegas, NV · +17 more sites
RecruitingPhase 3NCT07011745
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
Sponsor: Bristol-Myers Squibb
Las Vegas, NV · +41 more sites
RecruitingPhase 3NCT07037433
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Sponsor: Amgen
Las Vegas, NV · +138 more sites
RecruitingPhase 2NCT07219173
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
Sponsor: Eli Lilly and Company
Las Vegas, NV · +16 more sites
RecruitingPhase 3NCT07222800
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Sponsor: Pfizer
Henderson, NV · Las Vegas, NV · +251 more sites
RecruitingPhase 2NCT07300969
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
Sponsor: Draig Therapeutics Ltd
Las Vegas, NV · +22 more sites
RecruitingPhase 2NCT07415044
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Sponsor: Eli Lilly and Company
Las Vegas, NV · +51 more sites
RecruitingPhase 2NCT07483073
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Sponsor: Eli Lilly and Company
Las Vegas, NV · +13 more sites
RecruitingPhase 2NCT07483099
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Sponsor: Eli Lilly and Company
Las Vegas, NV · +13 more sites
RecruitingPhase 2NCT07589608
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Sponsor: Eli Lilly and Company
Las Vegas, NV · +39 more sites
RecruitingPhase 2NCT07783802
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Sponsor: Eli Lilly and Company
Las Vegas, NV · +28 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.